DK1711169T3 - Coatede mikrodepottabletter med venlafaxinhydrochlorid - Google Patents

Coatede mikrodepottabletter med venlafaxinhydrochlorid

Info

Publication number: DK1711169T3
Authority: DK; Denmark
Prior art keywords: tablets; microdeposition; coated; venlafaxine hydrochloride; relates
Prior art date: 2004-02-04

Application number

DK04821278T

Other languages

English (en)

Inventor

Rajesh Kshirsagar

Mayank Joshi

Sandeep Pandita

Sampad Bhattacharya

Original Assignee

Alembic Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-02-04

Filing date

2004-10-27

Publication date

2007-09-17

2004-10-27 Application filed by Alembic Ltd filed Critical Alembic Ltd

2007-09-17 Application granted granted Critical

2007-09-17 Publication of DK1711169T3 publication Critical patent/DK1711169T3/da

Links

229960002416 venlafaxine hydrochloride Drugs 0.000 title abstract 2
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title abstract 2
238000013265 extended release Methods 0.000 abstract 2
239000007903 gelatin capsule Substances 0.000 abstract 1
239000008185 minitablet Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK04821278T 2004-02-04 2004-10-27 Coatede mikrodepottabletter med venlafaxinhydrochlorid DK1711169T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IN117MU2004		2004-02-04
IN980MU2004		2004-09-13
PCT/IN2004/000340 WO2005074895A1 (en)	2004-02-04	2004-10-27	Extended release coated microtablets of venlafaxine hydrochloride

Publications (1)

Publication Number	Publication Date
DK1711169T3 true DK1711169T3 (da)	2007-09-17

Family

ID=34809925

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04821278T DK1711169T3 (da)	2004-02-04	2004-10-27	Coatede mikrodepottabletter med venlafaxinhydrochlorid

Country Status (23)

Country	Link
US (1)	US7807195B2 (da)
EP (1)	EP1711169B1 (da)
JP (1)	JP2007520547A (da)
KR (1)	KR20070000439A (da)
AT (1)	ATE361743T1 (da)
AU (1)	AU2004315136B2 (da)
BR (1)	BRPI0418283A (da)
CA (1)	CA2555295C (da)
CY (1)	CY1106741T1 (da)
DE (1)	DE602004006443T2 (da)
DK (1)	DK1711169T3 (da)
ES (1)	ES2287813T3 (da)
HR (1)	HRP20070353T3 (da)
IL (1)	IL177243A0 (da)
MX (1)	MXPA06008854A (da)
NO (1)	NO20063809L (da)
NZ (1)	NZ548504A (da)
PL (1)	PL1711169T3 (da)
PT (1)	PT1711169E (da)
RU (1)	RU2340331C2 (da)
SI (1)	SI1711169T1 (da)
UA (1)	UA82597C2 (da)
WO (1)	WO2005074895A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL146462A (en)	2001-11-13	2015-02-26	Lycored Bio Ltd	Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
ZA200505180B (en) *	2002-11-28	2006-10-25	Themis Lab Private Ltd	Process for manufacturing sustained release microbeads containing venlafaxine HCI
WO2006136927A1 (en) *	2005-06-22	2006-12-28	Glenmark Pharmaceuticals Limited	Extended release formulations comprising venlafaxine
EP1906935A4 (en) *	2005-07-28	2010-10-20	Reddys Lab Ltd Dr	VENLAFAXIN COMPOSITIONS WITH EXTENDED RELEASE
WO2007102169A1 (en) *	2006-03-08	2007-09-13	Jubilant Organosys Limited	Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same
CN101453996B (zh) *	2006-04-03	2016-05-11	伊萨·奥迪迪	药物递送组合物
WO2007112574A1 (en) *	2006-04-03	2007-10-11	Isa Odidi	Extended release composition of venlafaxine
WO2007129329A2 (en) *	2006-05-08	2007-11-15	Jubilant Organosys Limited	Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
US20100179110A1 (en) *	2006-12-20	2010-07-15	Mostafa Akbarieh	Composition Containing a Bisphosphonic Acid in Combination with Vitamin D
EP2114455A4 (en) *	2006-12-20	2010-03-17	Mylan Pharmaceuticals Ulc	PHARMACEUTICAL COMPOSITION USING A HOT-MELT GRANULATED AGENT
TWI391150B (zh) *	2008-01-22	2013-04-01	Taiwan Biotech Co Ltd	腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) *	2008-12-10	2010-06-30	上海复星普适医药科技有限公司	文拉法辛缓释制剂的制备方法
KR101787481B1 (ko)	2010-10-21	2017-10-18	롯데정밀화학 주식회사	장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
US9789093B2 (en)	2011-01-31	2017-10-17	Serotech, Llc	Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
WO2017111005A1 (ja)	2015-12-25	2017-06-29	富山化学工業株式会社	１－（３－（２－（１－ベンゾチオフェン－５－イル）エトキシ）プロピル）アゼチジン－３－オールまたはその塩を含む錠剤
KR102062052B1 (ko) *	2018-03-20	2020-01-03	일양약품주식회사	베타네콜 서방성 제제 및 이의 제조방법
KR20230067863A (ko)	2021-11-10	2023-05-17	박찬호	스마트 계량도구 및 이를 이용한 요리보조 시스템

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4153677A (en) *	1978-05-18	1979-05-08	Sterling Drug Inc.	Controlled-release composition
US4535186A (en)	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en)	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
US6274171B1 (en) *	1996-03-25	2001-08-14	American Home Products Corporation	Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es)	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
UA77145C2 (en) *	1997-11-05	2006-11-15	Wyeth Corp	Extended release dosage formulation
CA2327285C (en) *	1998-05-15	2005-06-14	Warner-Lambert Company	Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
EP1233761B1 (en)	1999-11-22	2007-03-28	ALZA Corporation	Osmotic dosage form comprising first and second coats
US6346269B1 (en) *	2000-05-08	2002-02-12	Standard Chem. & Pharm. Co., Ltd.	Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) *	2000-05-31	2002-02-26	Pharma Pass Llc	Tablet comprising a delayed release coating
WO2002085335A1 (en) *	2001-04-18	2002-10-31	Nostrum Pharmaceuticals Inc.	A novel coating for a sustained release pharmaceutical composition
US20030091634A1 (en) *	2001-09-14	2003-05-15	Pawan Seth	Delayed release tablet of venlafaxin
MXPA04006163A (es)	2001-12-20	2004-11-01	Pharmacia Corp	Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
WO2003055475A1 (en) *	2002-01-03	2003-07-10	Lek Pharmaceutical And Chemical Company D.D.	Controlled release pharmaceutical formulation containing venlafaxine
WO2003103637A2 (en) *	2002-01-10	2003-12-18	Ranbaxy Laboratories Limited	Modified release, multiple unit drug delivery systems
US20030191347A1 (en) *	2002-03-28	2003-10-09	Rolf Keltjens	Venlafaxine base
WO2003082805A1 (en) *	2002-03-28	2003-10-09	Synthon B.V.	Low water-soluble venlafaxine salts
IL149055A0 (en) *	2002-04-09	2002-11-10	Karma Pharm Ltd	Extended release composition comprising as active compound venlafaxine hydrochloride
US8216609B2 (en)	2002-08-05	2012-07-10	Torrent Pharmaceuticals Limited	Modified release composition of highly soluble drugs
US7058999B2 (en) *	2002-10-24	2006-06-13	Paramount Bed Co., Ltd.	Electric bed and control apparatus and control method therefor
US6703044B1 (en) *	2002-10-25	2004-03-09	Dexcel Pharma Tech, Ltd	Venlafaxine formulations
WO2004037226A2 (en) *	2002-10-25	2004-05-06	Dexcel Pharma Technologies Ltd.	Pharmaceutical compositions containing venlafaxine
WO2004069228A2 (en) *	2003-02-07	2004-08-19	Omega Farma Ehf.	Sustained release formulations of venlafaxine
DK1502587T3 (da) *	2003-07-30	2007-01-02	Pharmathen Sa	Formulering med vedvarende frigivelse af venlafaxinhydrochlorid
US7016014B2 (en) *	2004-02-27	2006-03-21	Asml Netherlands B.V	Lithographic apparatus and device manufacturing method

2004
- 2004-10-27 RU RU2006129034/15A patent/RU2340331C2/ru not_active IP Right Cessation
- 2004-10-27 SI SI200430372T patent/SI1711169T1/sl unknown
- 2004-10-27 BR BRPI0418283-9A patent/BRPI0418283A/pt not_active IP Right Cessation
- 2004-10-27 PT PT04821278T patent/PT1711169E/pt unknown
- 2004-10-27 AU AU2004315136A patent/AU2004315136B2/en not_active Ceased
- 2004-10-27 MX MXPA06008854A patent/MXPA06008854A/es active IP Right Grant
- 2004-10-27 DK DK04821278T patent/DK1711169T3/da active
- 2004-10-27 NZ NZ548504A patent/NZ548504A/en unknown
- 2004-10-27 AT AT04821278T patent/ATE361743T1/de not_active IP Right Cessation
- 2004-10-27 DE DE602004006443T patent/DE602004006443T2/de not_active Expired - Fee Related
- 2004-10-27 PL PL04821278T patent/PL1711169T3/pl unknown
- 2004-10-27 JP JP2006552018A patent/JP2007520547A/ja active Pending
- 2004-10-27 KR KR1020067014903A patent/KR20070000439A/ko not_active Ceased
- 2004-10-27 WO PCT/IN2004/000340 patent/WO2005074895A1/en not_active Ceased
- 2004-10-27 UA UAA200608949A patent/UA82597C2/uk unknown
- 2004-10-27 ES ES04821278T patent/ES2287813T3/es not_active Expired - Lifetime
- 2004-10-27 EP EP04821278A patent/EP1711169B1/en not_active Expired - Lifetime
- 2004-10-27 CA CA2555295A patent/CA2555295C/en not_active Expired - Fee Related
- 2004-10-27 HR HR20070353T patent/HRP20070353T3/xx unknown
2005
- 2005-01-07 US US11/031,266 patent/US7807195B2/en not_active Expired - Fee Related
2006
- 2006-08-02 IL IL177243A patent/IL177243A0/en unknown
- 2006-08-25 NO NO20063809A patent/NO20063809L/no not_active Application Discontinuation
2007
- 2007-07-19 CY CY20071100959T patent/CY1106741T1/el unknown

Also Published As

Publication number	Publication date
NZ548504A (en)	2009-03-31
IL177243A0 (en)	2006-12-10
CY1106741T1 (el)	2012-05-23
PL1711169T3 (pl)	2007-10-31
ES2287813T3 (es)	2007-12-16
NO20063809L (no)	2006-08-25
US20050169985A1 (en)	2005-08-04
AU2004315136A1 (en)	2005-08-18
RU2006129034A (ru)	2008-03-10
MXPA06008854A (es)	2007-01-23
DE602004006443T2 (de)	2008-01-10
HRP20070353T3 (en)	2008-01-31
PT1711169E (pt)	2007-07-23
US7807195B2 (en)	2010-10-05
EP1711169A1 (en)	2006-10-18
ATE361743T1 (de)	2007-06-15
SI1711169T1 (sl)	2007-10-31
WO2005074895A1 (en)	2005-08-18
DE602004006443D1 (de)	2007-06-21
HK1091137A1 (en)	2007-01-12
JP2007520547A (ja)	2007-07-26
AU2004315136B2 (en)	2010-06-17
KR20070000439A (ko)	2007-01-02
UA82597C2 (uk)	2008-04-25
EP1711169B1 (en)	2007-05-09
CA2555295A1 (en)	2005-08-18
RU2340331C2 (ru)	2008-12-10
CA2555295C (en)	2011-01-18
BRPI0418283A (pt)	2007-05-02

Publication	Publication Date	Title
ATE361743T1 (de)	2007-06-15	Beschichtete minitabletten von venlafaxinhydrochlorid mit verlängerter freisetzung
AP2012006231A0 (en)	2012-04-30	Capsule formulation of pirfenidone and pharmaceutically acceptable excipients.
WO2008027557A3 (en)	2008-10-30	Topiramate compositions and methods of enhancing its bioavailability
PH12013502277A1 (en)	2020-10-19	Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
EA200900264A1 (ru)	2009-08-28	Композиции флибансерина и способ их приготовления
JO2973B1 (en)	2016-03-15	Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
MX2009001711A (es)	2009-05-08	Formulaciones de liberacion sostenida de topiramato.
UA94942C2 (ru)	2011-06-25	Фармацевтические композиции с ингибиторами dpp iv
EA200801926A1 (ru)	2009-04-28	Таблетки парацетамола с быстрым высвобождением
NO20081038L (no)	2008-04-23	Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
WO2008049657A3 (de)	2008-10-30	Verwendung von (meth)acrylat-copolymeren in retard-arzneiformen zur verringerung des einflusses von ethanol auf die wirkstofffreisetzung
SG152257A1 (en)	2009-05-29	Topical preparation containing ambroxol
BRPI0513598A (pt)	2008-05-13	formas de dosagem em comprimidos revestidos de liberação entérica
UY30126A1 (es)	2007-09-28	Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
CO6351711A2 (es)	2011-12-20	Combinacion de dosis fija en la forma de una tableta de dos copas o de una sola capa de alisquireno y amlodipina
MA31227B1 (fr)	2010-03-01	Composition pharmaceutique renfermant du phloroglucinol et du paracetamol.
TNSN06242A1 (en)	2007-12-03	Extended release coated minitablets of venlafaxine hydrochloride
ATE460934T1 (de)	2010-04-15	Pharmazeutische zubereitungen von ciprofloxacin
AR067502A1 (es)	2009-10-14	Pelets de administracion oral y liberacion retardada de clorhidrato de duloxetina
MX2009006735A (es)	2009-06-30	Capsulas de gelatina que comprenden un acido.
TW200716114A (en)	2007-05-01	Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
WO2007119249A3 (en)	2008-05-22	Pharmaceutical compositions of cefixime
WO2012010942A3 (en)	2012-05-24	Novel pharmaceutical composition(s) of hiv protease inhibitor(s)
TN2013000440A1 (en)	2015-03-30	Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
PL400338A1 (pl)	2014-02-17	Stala doustna postac dawkowania zawierajaca L-jablczan sunitynibu